Primary Site >> Pancreatic Cancer

Gene >> CD52

  • 2000
  • 2016
Ref: Emerging Therapies: Spectrum of Applications of Monoclonal Antibody Therapy.
PMID: 11701553
Ref: Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies.
PMID: 26549384